They identified key factors, such as tumour size and genetic markers like Ki-67 and p53, that correlated with overall survival (OS) and disease- free survival (DFS), with distinct lipid profile changes influencing treatment response, particularly in triplenegative breast cancer (TNBC). Here, MKI67 is linked to neoplasm.